Automated Suturing Devices Market Growth Trends 2022 Latest Challenges, Business Share and Size Forecast to 2032


 It is predicted that the Automated Suturing Devices Market will generate US$ 3.02 billion in 2022 and US$ 6.2 billion by 2032. The market for automated suturing devices is anticipated to grow at a CAGR of 7.46% between 2022 and 2032. The increase of the market can be ascribed to the rise in chronic disease prevalence and the preference for minimally invasive surgeries (MIS) over traditional surgical techniques.

ESOMAR-certified consulting firm Future Market Insight (FMI) presents incisive global automated suturing devices market survey for the forecast period of 2021-2031. According to the report, the market is expected to expand, rising at a CAGR of 7.3 % during the forecast period.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-579  

Surgical suture devices find application in laparoscopy, orthopedic surgery, cardiovascular surgery, gynecology, orthopedic, and ophthalmology as they are majorly used for treating wounds and injuries.

Rising cases of surgeries due to increasing accidents and trauma cases are boosting demand for automated suturing devices in the global market. According to the Ministry of Road Transport and Highways, India, in 2018, the nation was leading in road accident deaths followed by United States and China.

According to the World Health Organization’s (WHO’s), Global Report on Road Safety 2018, India accounted for 11% accident related deaths in the world. A total of 4,67,044 road accidents, 51,417 deaths, and 4,69,418 injuries. The rise in number of accidents and the increasing need for surgeries will propel the need for automated suturing devices, thereby augmenting the growth of the market.

Automated suturing devices are preferred over conventional suturing as they aid in delivering better wound healing and lowers post-surgery duration of hospital stay. That’s why it is extensively used for open and minimally invasive surgeries.

Key Takeaways from FMI’s Automated Suturing Devices Market Study

  • The automated suturing devices market in the U.S. will witness positive growth owing to rising prevalence of cardiovascular diseases and requirement for invasive procedures in the country.
  • France will find lucrative opportunities during the forecast period as according to the Organization of Economic Cooperation and Development, approximately 148075 minimal invasive surgeries took place in France in 2018. The country also has presence of several manufacturers such as Guerbet, Sanofi, and others.
  • Disposable automated suturing devices are expected to lead the product segment as they are cost-effective. Rising demand for laparoscopy and minimally invasive procedures are also encouraging demand for the same.
  • Hospitals will exhibit high demand for automated suturing devices since they receive a higher footfall of patients on a daily basis.

“Several leading players are aiming for clearance from the United States Food and Drug Administration to launch advanced automated suturing devices. With focus on technological improvements on cards, the market is expected to gain momentum in the coming years,” says a FMI analyst.

Who is Winning?

Key players in the global automated suturing devices market are focusing on adopting inorganic strategies such as alliance, collaboration, partnerships, and merger and acquisitions to strengthen their position in the supply chain channels.

They are also emphasizing on launching new products and expanding their product portfolio. Key players operating in the global automated suturing devices market are Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery, EndoEvolution, LLC, LSI Solutions, Inc., and SuturTek Inc.

On March 3rd 2020, Origami Surgical launched StitchKit, a patented suture delivery and retrieval system. The U.S. Food and Drug Administration (FDA) approved 510k clearance for three novel types of sutures for the company’s StitchKit robotic surgery platform.

On November 2020, Healthium Medtech, one of India’s largest medical devices company, launched Trubarb, its latest innovation. This innovation is a knotless tissue closure device that reforms the suturing experience.

On June 1st 2021, Anchora Medical, a Alon Medtech Venture’s company, announced closing of $4.5million financing led by HOYA Corporation and Tal Capital. The funds will be utilized for completing Anchora’s single use laparoscopic suturing devices.

Key Segments:

Product

  • Reusable Automated Suturing Devices
  • Disposable Automated Suturing Devices

Applications

  • Minimally Invasive Surgeries
  • Open Surgeries
  • Trauma Cases

End Use

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more